²é¿´: 455  |  »Ø¸´: 1
±¾Ìû²úÉú 1 ¸ö £¬µã»÷ÕâÀï½øÐв鿴

xiandongzeng

ľ³æ (ÕýʽдÊÖ)

[ÇóÖú] ÇóÖúWOSÈë²ØºÅ

ÇóÖúWOSÈë²ØºÅ,DcR3 combined with hematological traits serves as a valuable biomarker for the diagnosis of cancer metastasis, Oncotarget, 2017,8(64): 107612¨C107620.

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

baiyuefei

°æÖ÷ (ÎÄѧ̩¶·)

·çÑ©

ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
xiandongzeng: ½ð±Ò+5, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, 3Ks 2018-09-18 09:12:29
Ðľ²_ÒÀÈ»: LS-EPI+1, ¸ÐлӦÖú 2018-09-19 08:37:31
DcR3 combined with hematological traits serves as a valuable biomarker for the diagnosis of cancer metastasis
×÷Õß:Li, JX (Li, Junxin)[ 1,2 ] ; Xie, N (Xie, Ni)[ 3 ] ; Yuan, JH (Yuan, Jianhui)[ 4 ] ; Liu, LY (Liu, Lvyan)[ 1 ] ; Zhou, QM (Zhou, Qiming)[ 5 ] ; Ren, XH (Ren, Xiaohu)[ 4 ] ; Chen, Q (Chen, Qian)[ 1,2 ] ; Zhang, GZ (Zhang, Guizhong)[ 1 ] ; Ruan, QG (Ruan, Qingguo)[ 1 ] ; Chen, YHH (Chen, Youhai H.)[ 6 ] ...¸ü¶àÄÚÈÝ

ONCOTARGET

¾í: 8  ÆÚ: 64  Ò³: 107612-107620
DOI: 10.18632/oncotarget.22544

³ö°æÄêEC 8 2017

ÎÄÏ×ÀàÐÍ:Article

²é¿´ÆÚ¿¯Ó°ÏìÁ¦

ÕªÒª
Decoy receptor 3 (DcR3) is abnormally up-regulated in many cancer cells. It may help cancer cells to escape from immune surveillance and establish metastatic lesions. However, whether DcR3 can be used as a biomarker for the diagnosis of cancer metastasis is unclear. In this study, sera from healthy controls and patients with different cancers were collected, and tested for their DcR3 levels by ELISA. Significantly elevated DcR3 levels were observed in the sera of patients with gastric cancer (2.04 +/- 1.01, P = 0.0061), lymphoma (1.62 +/- 0.75, P = 0.041), and breast cancer (1.53 +/- 0.51, P = 0.023). DcR3 was found to be a suitable biomarker for identifying gastric cancer patients. Importantly, DcR3 was positively associated with platelet distribution width (PDW) (P = 2.45 x 10(-6), R = 0.63) in metastatic cancers but negatively associated with hemoglobin (HGB) (P = 0.002, R = -0.59) and hematocrit (HCT) (P = 0.001, R = -0.62) in non-metastatic cancers. Combined with PDW, HGB and HCT, serum DcR3 could be used to predict the occurrence of cancer metastasis. These findings indicate that DcR3 could be used as a biomarker for the diagnosis of gastric cancer, and for cancer metastasis in combination with hematological traits.

¹Ø¼ü´Ê
×÷Õ߹ؼü´ÊcR3; PDW; HGB; HCT; metastasis

KeyWords PlusECOY RECEPTOR-3; E-CADHERIN; GASTRIC-CANCER; CELL-ADHESION; COLON-CANCER; EXPRESSION; PROGRESSION; CARCINOMA; APOPTOSIS; CATENIN

×÷ÕßÐÅÏ¢
ͨѶ×÷ÕßµØÖ·: Wan, XC (ͨѶ×÷Õß)

ÏÔʾ¸ü¶à        Univ City Shenzhen, Shenzhen Lab Fully Human Antibody Engn, Inst Biomed & Biotechnol, Shenzhen Inst Adv Technol,Chinese Acad Sci, Shenzhen 518055, Peoples R China.
µØÖ·:

ÏÔʾ¸ü¶à        [ 1 ] Univ City Shenzhen, Shenzhen Lab Fully Human Antibody Engn, Inst Biomed & Biotechnol, Shenzhen Inst Adv Technol,Chinese Acad Sci, Shenzhen 518055, Peoples R China
ÏÔʾ¸ü¶à        [ 2 ] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
ÏÔʾ¸ü¶à        [ 3 ] Shenzhen Second Peoples Hosp, Inst Translat Med, Shenzhen 518035, Peoples R China
              [ 4 ] Shenzhen Ctr Dis Control & Prevent, Inst Toxicol, Shenzhen 518055, Peoples R China
              [ 5 ] Nanshan Hosp Shenzhen, Dept Oncol, Shenzhen 518055, Peoples R China
ÏÔʾ¸ü¶à        [ 6 ] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
µç×ÓÓʼþµØÖ·:xc.wan@siat.ac.cn

»ù½ð×ÊÖúÖÂл
»ù½ð×ÊÖú»ú¹¹        ÊÚȨºÅ
Shenzhen Peacock Team Project        
1110140040347265
Fourth Batch of Talents Project in Guangdong Province        
2014-1
Nature Science Foundation of China        
81373112
Shenzhen Special Funds of Industry in the Future        
2015-971
Shenzhen Municipal Development and Reform Commission (NDRC) Engineering Laboratory Project        
2014-1782
Project of Guangdong Natural Science Foundation        
2016A030310033
Project of Shenzhen Basic Research Plan        
JCYJ20150402102135491
JCYJ201603 28161613864
Shenzhen Technology Innovation Progect        
JSGG20160229202150023
JSGG20140701164558078
JCYJ20150330102720122
Project of Shenzhen International Cooperation Foundation        
GJHZ201603 01163138685
GJHZ20130412153906740
Natural Science Foundation of Guangdong        
2016A030313029
Natural Science Foundation of China        
81501356
Project of Guangdong Scientific Plan Foundation        
2013A022100037
2013B021800097
2014A020212038
²é¿´»ù½ð×ÊÖúÐÅÏ¢   
³ö°æÉÌ
IMPACT JOURNALS LLC, 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA

Àà±ð / ·ÖÀà
Ñо¿·½Ïò:Oncology; Cell Biology

Web of Science Àà±ð:Oncology; Cell Biology

ÎÄÏ×ÐÅÏ¢
ÓïÑÔ:English

Èë²ØºÅ: WOS:000419564600024

PubMed ID: 29296192

ISSN: 1949-2553

ÆäËûÐÅÏ¢
IDS ºÅ: FS1UR

Web of Science ºËÐĺϼ¯ÖÐµÄ "ÒýÓõIJο¼ÎÄÏ×": 41

Web of Science ºËÐĺϼ¯ÖÐµÄ "±»ÒýƵ´Î": 0
2Â¥2018-09-18 08:48:11
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ xiandongzeng µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] һ־Ըɽ´ó07»¯Ñ§ 332·Ö ËÄÁù¼¶Òѹý ±¾¿ÆÉ½¶«Ë«·Ç Çóµ÷¼Á£¡ +3 ²»ÏëÀíÄã 2026-03-16 3/150 2026-03-21 03:59 by JourneyLucky
[¿¼ÑÐ] 307Çóµ÷¼Á +10 ÀäóÏ123 2026-03-17 10/500 2026-03-21 01:54 by JourneyLucky
[¿¼ÑÐ] 295Çóµ÷¼Á +4 Ò»Ö¾Ô¸¾©Çø211 2026-03-18 6/300 2026-03-20 23:41 by JourneyLucky
[¿¼ÑÐ] Ò»Ö¾Ô¸Äϲý´óѧ£¬327·Ö£¬²ÄÁÏÓ뻯¹¤085600 +9 Ncdx123456 2026-03-19 9/450 2026-03-20 23:41 by lovewei0727
[¿¼ÑÐ] 288Çóµ÷¼Á +16 ÓÚº£º£º£º£ 2026-03-19 16/800 2026-03-20 22:28 by JourneyLucky
[¿¼ÑÐ] Ò»Ö¾Ô¸»ªÖÐũҵ071010£¬×Ü·Ö320Çóµ÷¼Á +3 À§À§À§À§À¤À¤ 2026-03-20 3/150 2026-03-20 20:38 by ѧԱ8dgXkO
[¿¼ÑÐ] 261ÇóBÇøµ÷¼Á£¬¿ÆÑо­Àú·á¸» +3 Å£Ä̺Üæ 2026-03-20 4/200 2026-03-20 19:34 by JourneyLucky
[¿¼ÑÐ] 086500 325 Çóµ÷¼Á +3 Áì´øÐ¡ÐÜ 2026-03-19 3/150 2026-03-20 18:38 by ¾¡Ë´Ò¢1
[¿¼ÑÐ] ¹¤¿Æ²ÄÁÏ085601 279Çóµ÷¼Á +7 À§ÓÚÐdz¿ 2026-03-17 9/450 2026-03-20 17:38 by ÎÞи¿É»÷111
[¿¼ÑÐ] ÉúÎïѧµ÷¼ÁÕÐÈË£¡£¡£¡ +3 ɽº£Ììá° 2026-03-17 4/200 2026-03-19 21:34 by ÔõôÊÍ»³
[¿¼ÑÐ] 0703»¯Ñ§µ÷¼Á +4 18889395102 2026-03-18 4/200 2026-03-19 16:13 by 30660438
[¿¼ÑÐ] 085600²ÄÁÏÓ뻯¹¤Çóµ÷¼Á +6 Ð÷ÐÒÓë×Ó 2026-03-17 6/300 2026-03-19 13:27 by houyaoxu
[¿¼ÑÐ] ¡¾Í¬¼ÃÈí¼þ¡¿Èí¼þ£¨085405£©¿¼ÑÐÇóµ÷¼Á +3 2026eternal 2026-03-18 3/150 2026-03-18 19:09 by ²«»÷518
[¿¼ÑÐ] 0854¿É¿çµ÷¼Á£¬Ò»×÷Ò»ÏîºËÐÄÂÛÎÄÎåÏîרÀû£¬Ê¡¡¢¹ú¼¶Ö¤Êé40+ÊýÒ»Ó¢Ò»287 +8 СÀî0854 2026-03-16 8/400 2026-03-18 14:35 by ²«»÷518
[¿¼ÑÐ] 312Çóµ÷¼Á +8 İå·Ï£ 2026-03-16 9/450 2026-03-18 12:39 by Linda Hu
[¿¼ÑÐ] 0854£¬¼ÆËã»úÀàÕÐÊÕµ÷¼Á +3 ºúÀ±ÌÀ·ÅÌÇ 2026-03-15 6/300 2026-03-18 12:09 by Éϰ¶Éϰ¶¡­¡­..
[¿¼ÑÐ] ÉúÎïѧ071000 329·ÖÇóµ÷¼Á +3 ÎÒ°®ÉúÎïÉúÎﰮΠ2026-03-17 3/150 2026-03-18 10:12 by macy2011
[¿¼ÑÐ] 293Çóµ÷¼Á +11 zjlµÄºÅ 2026-03-16 16/800 2026-03-18 08:10 by zhukairuo
[¿¼ÑÐ] ²ÄÁÏר˶326Çóµ÷¼Á +6 Ä«ìÏæ¦Ý· 2026-03-15 7/350 2026-03-17 17:10 by ruiyingmiao
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á +3 ºôºô£¿~+123456 2026-03-14 3/150 2026-03-14 16:53 by WTUChen
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û